| Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 108.23 mm | 108.23 mm | 108.23 mm | 108.23 mm | 108.23 mm | 108.23 mm |
| Cash burn (monthly) | (no burn) | 5.57 mm | 10.39 mm | 8.35 mm | 6.42 mm | 6.86 mm |
| Cash used (since last report) | n/a | 12.96 mm | 24.18 mm | 19.44 mm | 14.93 mm | 15.97 mm |
| Cash remaining | n/a | 95.27 mm | 84.05 mm | 88.79 mm | 93.29 mm | 92.26 mm |
| Runway (months of cash) | n/a | 17.1 | 8.1 | 10.6 | 14.5 | 13.4 |
| 13F holders | Current |
|---|---|
| Total holders | 137 |
| Opened positions | 30 |
| Closed positions | 14 |
| Increased positions | 34 |
| Reduced positions | 42 |
| 13F shares | Current |
|---|---|
| Total value | 147.56 bn |
| Total shares | 141.79 mm |
| Total puts | 453.30 k |
| Total calls | 77.20 k |
| Total put/call ratio | 5.9 |
| Largest owners | Shares | Value |
|---|---|---|
| Nextech Invest | 12.07 mm | $17.26 bn |
| Nextech Crossover I GP S.a r.l. | 12.07 mm | $7.47 mm |
| EcoR1 Capital | 11.33 mm | $16.20 bn |
| VR Adviser | 10.26 mm | $14.67 bn |
| Venrock Healthcare Capital Partners III | 10.26 mm | $6.53 mm |
| BlackRock | 9.21 mm | $13.16 bn |
| Bain Capital Life Sciences Investors | 8.66 mm | $12.39 bn |
| Vanguard | 7.06 mm | $10.09 bn |
| Bain Capital Life Sciences Fund II | 4.97 mm | $10.98 mm |
| Novo Holdings A/S | 4.25 mm | $6.08 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 16 Jan 25 | Brian DeSchuytner | Common Stock | Sell | Dispose S | No | Yes | 0.58 | 8,470 | 4.91 k | 121,393 |
| 16 Jan 25 | Huber Martin H. Jr. | Common Stock | Sell | Dispose S | No | Yes | 0.58 | 4,514 | 2.62 k | 122,875 |
| 16 Jan 25 | Carvajal Alejandra | Common Stock | Sell | Dispose S | No | Yes | 0.58 | 5,096 | 2.96 k | 78,296 |
| 16 Jan 25 | Timothy B Lowinger | Common Stock | Sell | Dispose S | No | Yes | 0.58 | 8,048 | 4.67 k | 257,673 |
| 16 Jan 25 | Mandelia Ashish | Common Stock | Sell | Dispose S | No | Yes | 0.58 | 3,554 | 2.06 k | 57,519 |
| 15 Jan 25 | Brian DeSchuytner | Common Stock | Option exercise | Acquire M | No | No | 0 | 14,583 | 0.00 | 129,863 |
| 15 Jan 25 | Brian DeSchuytner | Common Stock | Option exercise | Acquire M | No | No | 0 | 6,250 | 0.00 | 115,280 |
| 15 Jan 25 | Brian DeSchuytner | RSU Common Stock | Grant | Acquire A | No | No | 0 | 62,500 | 0.00 | 62,500 |
| 15 Jan 25 | Brian DeSchuytner | Stock Option Common Stock | Grant | Acquire A | No | No | 0.64 | 281,250 | 180.00 k | 281,250 |
| 15 Jan 25 | Brian DeSchuytner | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 14,583 | 0.00 | 43,750 |
